Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR‐383‐5p/vesicle‐associated membrane protein‐2 axis

Abstract We aimed to explore the function and underlying mechanism of highly upregulated in liver cancer (HULC; an long noncoding RNAs) in hepatocellular carcinoma (HCC) and chemosensitivity of oxaliplatin (Oxa). The expression of HULC, miR‐383‐5p, and vesicle‐associated membrane protein‐2 (VAMP2) w...

Full description

Bibliographic Details
Main Authors: Peng Li, Yuwei Li, Lieting Ma
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:Pharmacology Research & Perspectives
Subjects:
Online Access:https://doi.org/10.1002/prp2.815
_version_ 1818695876591222784
author Peng Li
Yuwei Li
Lieting Ma
author_facet Peng Li
Yuwei Li
Lieting Ma
author_sort Peng Li
collection DOAJ
description Abstract We aimed to explore the function and underlying mechanism of highly upregulated in liver cancer (HULC; an long noncoding RNAs) in hepatocellular carcinoma (HCC) and chemosensitivity of oxaliplatin (Oxa). The expression of HULC, miR‐383‐5p, and vesicle‐associated membrane protein‐2 (VAMP2) was detected by quantitative real‐time polymerase chain reaction. Western blot assay was applied for measuring the protein expression of cyclinD1, cleaved‐caspase‐3, light Chain 3 I/II, p62, and VAMP2. Cell viability and Oxa IC50 value were determined by Cell Counting Kit‐8 assay. A colony formation assay was conducted to evaluate colony formation ability. Cell apoptosis was assessed by flow cytometry. The interaction between miR‐383‐5p and HULC or VAMP2 was predicted by bioinformatics analysis and verified by dual‐luciferase reporter assay and RNA immunoprecipitation assay. The mice xenograft model was established to investigate the roles of HULC in vivo. HULC and VAMP2 were overexpressed whereas miR‐383‐5p was lowly expressed in HCC tissues. HULC overexpression promoted the progression of HCC cells and inhibited chemosensitivity of Oxa by increasing cell proliferation and protective autophagy and inhibiting apoptosis, whereas HULC silence presented opposite effects. Moreover, miR‐383‐5p was a direct target of HULC and miR‐383‐5p reversed the effects of HULC on the progression of HCC cells and chemosensitivity of Oxa. Besides, HULC acted as a molecular sponge of miR‐383‐5p to regulate VAMP2 expression. HULC promoted the progression of HCC and inhibited Oxa sensitivity by regulating miR‐383‐5p/VAMP2 axis, elucidating a novel regulatory mechanism for chemosensitivity of Oxa and providing a potential lncRNA‐targeted therapy for HCC.
first_indexed 2024-12-17T13:52:26Z
format Article
id doaj.art-b51f103ee9b9419f823c1ff9d4153135
institution Directory Open Access Journal
issn 2052-1707
language English
last_indexed 2024-12-17T13:52:26Z
publishDate 2021-08-01
publisher Wiley
record_format Article
series Pharmacology Research & Perspectives
spelling doaj.art-b51f103ee9b9419f823c1ff9d41531352022-12-21T21:46:01ZengWileyPharmacology Research & Perspectives2052-17072021-08-0194n/an/a10.1002/prp2.815Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR‐383‐5p/vesicle‐associated membrane protein‐2 axisPeng Li0Yuwei Li1Lieting Ma2Department of Laboratory First Affiliated Hospital of Xi'an Jiaotong University Xi’an PR ChinaDepartment of Genetic Center Northwest Women’s and Children’s Hospital Xi’an PR ChinaDepartment of Laboratory First Affiliated Hospital of Xi'an Jiaotong University Xi’an PR ChinaAbstract We aimed to explore the function and underlying mechanism of highly upregulated in liver cancer (HULC; an long noncoding RNAs) in hepatocellular carcinoma (HCC) and chemosensitivity of oxaliplatin (Oxa). The expression of HULC, miR‐383‐5p, and vesicle‐associated membrane protein‐2 (VAMP2) was detected by quantitative real‐time polymerase chain reaction. Western blot assay was applied for measuring the protein expression of cyclinD1, cleaved‐caspase‐3, light Chain 3 I/II, p62, and VAMP2. Cell viability and Oxa IC50 value were determined by Cell Counting Kit‐8 assay. A colony formation assay was conducted to evaluate colony formation ability. Cell apoptosis was assessed by flow cytometry. The interaction between miR‐383‐5p and HULC or VAMP2 was predicted by bioinformatics analysis and verified by dual‐luciferase reporter assay and RNA immunoprecipitation assay. The mice xenograft model was established to investigate the roles of HULC in vivo. HULC and VAMP2 were overexpressed whereas miR‐383‐5p was lowly expressed in HCC tissues. HULC overexpression promoted the progression of HCC cells and inhibited chemosensitivity of Oxa by increasing cell proliferation and protective autophagy and inhibiting apoptosis, whereas HULC silence presented opposite effects. Moreover, miR‐383‐5p was a direct target of HULC and miR‐383‐5p reversed the effects of HULC on the progression of HCC cells and chemosensitivity of Oxa. Besides, HULC acted as a molecular sponge of miR‐383‐5p to regulate VAMP2 expression. HULC promoted the progression of HCC and inhibited Oxa sensitivity by regulating miR‐383‐5p/VAMP2 axis, elucidating a novel regulatory mechanism for chemosensitivity of Oxa and providing a potential lncRNA‐targeted therapy for HCC.https://doi.org/10.1002/prp2.815hepatocellular carcinomaHULCmiR‐383‐5pOxa chemosensitivityVAMP2
spellingShingle Peng Li
Yuwei Li
Lieting Ma
Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR‐383‐5p/vesicle‐associated membrane protein‐2 axis
Pharmacology Research & Perspectives
hepatocellular carcinoma
HULC
miR‐383‐5p
Oxa chemosensitivity
VAMP2
title Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR‐383‐5p/vesicle‐associated membrane protein‐2 axis
title_full Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR‐383‐5p/vesicle‐associated membrane protein‐2 axis
title_fullStr Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR‐383‐5p/vesicle‐associated membrane protein‐2 axis
title_full_unstemmed Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR‐383‐5p/vesicle‐associated membrane protein‐2 axis
title_short Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR‐383‐5p/vesicle‐associated membrane protein‐2 axis
title_sort long noncoding rna highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating mir 383 5p vesicle associated membrane protein 2 axis
topic hepatocellular carcinoma
HULC
miR‐383‐5p
Oxa chemosensitivity
VAMP2
url https://doi.org/10.1002/prp2.815
work_keys_str_mv AT pengli longnoncodingrnahighlyupregulatedinlivercancerpromotestheprogressionofhepatocellularcarcinomaandattenuatesthechemosensitivityofoxaliplatinbyregulatingmir3835pvesicleassociatedmembraneprotein2axis
AT yuweili longnoncodingrnahighlyupregulatedinlivercancerpromotestheprogressionofhepatocellularcarcinomaandattenuatesthechemosensitivityofoxaliplatinbyregulatingmir3835pvesicleassociatedmembraneprotein2axis
AT lietingma longnoncodingrnahighlyupregulatedinlivercancerpromotestheprogressionofhepatocellularcarcinomaandattenuatesthechemosensitivityofoxaliplatinbyregulatingmir3835pvesicleassociatedmembraneprotein2axis